SGPGIMS Launches NGS Facility for TB Drug-Resistance Testing
The story in brief
SGPGIMS has set up Uttar Pradesh’s first Next Generation Sequencing facility for tuberculosis, using an Illumina MiSeq i100plus platform funded by Indian Oil Corporation. The facility, operational since September 14, 2026, will cut drug-resistance testing time from weeks to days. The first NGS workshop, 'From Sequence to Solution,' was held on the same day, training staff to use the technology. This will help clinicians plan TB treatments more effectively.